Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Loading SNTA News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||4.59%||11.17||13.5%||$294.79m|
|PRGO||Perrigo Co. Plc||0.26%||69.09||6.1%||$173.33m|
|SHPG||Shire PLC Sponsored ADR||0.45%||178.19||0.4%||$164.58m|
|ENDP||Endo International Plc||6.70%||11.46||9.5%||$144.45m|
|JAZZ||Jazz Pharmaceuticals Plc||0.10%||146.05||1.7%||$89.10m|
|UTHR||United Therapeutics Corporation||-1.72%||138.76||12.3%||$78.48m|
|PRXL||PAREXEL International Corporation||0.56%||63.05||6.5%||$65.78m|
|PCRX||Pacira Pharmaceuticals, Inc.||0.42%||47.60||13.6%||$63.08m|
|PTLA||Portola Pharmaceuticals, Inc.||-0.13%||39.18||9.6%||$46.60m|
|ICPT||Intercept Pharmaceuticals, Inc.||-0.16%||115.61||23.5%||$44.04m|
|HZNP||Horizon Pharma plc||4.93%||15.12||8.5%||$43.61m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||1.06%||121.40||8.8%||$38.17m|
Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.